WEE1-IN-5 is a potent WEE1 inhibitor with an IC 50 value of 0.8 nM. WEE1-IN-5 inhibits phospho-CDC2. WEE1-IN-5 abrogates the G2 check point, increasing sensitivity to DNA damaging agents in cancer cells. WEE1-IN-5 can be used for researching anticancer In Vitro WEE1-IN-5 exhibits an EC 50 of 188 nM in pCDC2 and an IC 50 shift for CYP3A4/5. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo WEE1-IN-5 (5mg/kg for PO; 1 mg/kg for IV; single dosage) exhibits a CL of 14 mL/min/kg, an AUC int 1324 h·ng/mL and bioavailability of 35% in SD rats . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:IC 50 : 0.8 nM (WEE1), 188 nM (CDC2)